2024 DOI: 10.1038/s41591-024-03018-2 PMID: 38858523 Read on PubMed Cell Metabolism LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Coskun T, Urva S, Roell WC, et al
For those who have been on GLP-1 medications and are concerned about weight regain after stopping Ozempic, our program specifically addresses the lifestyle infrastructure needed to maintain results long-term
However, this is extremely uncommon and not considered a primary cause of discomfort for most people
Moreover, iron deficiency in later stages of development, such as during childhood, may be associated with impaired cognitive development (see the article on Iron)
Wikipedia contributors, Al-Zahrawi, Wikipedia, The Free Encyclopedia, (accessed August 28, 2024) Wikipedia contributors, Avicenna, Wikipedia, The Free Encyclopedia, (accessed August 28, 2024)